Adjunct Staff

Darren Cunningham - Adjunct Professor

Co-founder and Chief Executive, Inflection Biosciences Ltd, a company developing small molecule therapeutics for the treatment of cancer. He is also a Non-Executive Director at Kora Healthcare. Prior to co-founding Inflection Biosciences Ltd, Darren spent 8 years at years at NASDAQ listed Amarin Corporation plc in a range of senior positions with responsibility covering corporate development and investor relations. Prior to Amarin, Darren was an Associate Director of Strategic Planning at publicly quoted drug company Elan Corporation plc. Darren holds a Bachelor of Commerce Degree from the National University of Ireland Galway, and a Masters in Accountancy from the Michael Smurfit Business School, University College Dublin. He trained at PricewaterhouseCoopers and is a Fellow of the Institute of Chartered Accountants in Ireland.

Orla Cunningham - Adjunct Professor

Senior Director at Pfizer.  Following a PhD in Biochemistry at Trinity College Dublin, Orla spent 5 years at the National Molecular Oncology Institute (IFOM) in Milan carrying out postdoctoral research in cancer cell biology. She returned to Ireland in 2006 to establish Wyeth's Protein Discovery & Optimization group in UCD using advanced protein engineering technology platforms to discover, evolve and optimize therapeutic antibodies.  The group subsequently moved to
the Pfizer Grange Castle site & continues to support antibody discovery & optimization across Pfizer’s diverse therapeutic research units based in the US including oncology, immunology, cardiovascular & rare diseases.  In addition, the team collaborate with the broader Irish biomedical community through the Science Foundation Ireland-Pfizer Biotherapeutics Award Program in a unique relationship that aims to bring together novel biology and cutting-edge drug discovery expertise. Orla is Senior Director of Pfizer’s BioMedicine Design group based in Grange Castle.

Michael Jordan - Adjunct Professor

Dr Michael Jordan is Director of Regulatory CMC at Prothena Biosciences. This is a global strategy role with accountability for the generation and submission of Drug Substance and Drug Product Chemistry,  Manufacturing and Control (CMC) filings for development products at different clinical phases.  The role works closely with new product and new facility start-up for the commercialization of bio pharmaceuticals leading to lifec-ycle management and post approval change management.

Dr Jordan has extensive knowledge in the pharmaceutical and bio pharmaceutical sectors from early stage development, to technology transfer and scale up, into life-cycle management and optimization to regulatory CMC submission, defense and approvals.

David Kent - Adjunct Professor

Dr David Kent is a consultant retina specialist (surgical & medical) who has worked in independent practice for the past 15 years. Dr Kent's primary research interest is in the area of retinal repair and regeneration and he has published extensively in this field in relation to age related macular degeneration (AMD) and diabetic retinopathy (DR).  He founded the Vision Clinic in 2008, with the express aim of combining clinical practice with retinal research and is currently researching the development of innovative immune-based therapies in AMD and DR.

Bartholomew (Bat) Masterson - Adjunct Professor

Dr Bat Masterson was formerly a Senior Lecturer in Biochemistry at UCD.  He is a member of the International Water Association and has had a long-standing involvement in research on the microbial pollution of recreational waters, including the SMART, iCREW and Smart Coasts = Sustainable Communities INTEREG funded projects and projects funded by the Irish EPA STRIVE programme.  He is currently active in two further Interreg funded projects, Acclimatize and SWIM.

Jaime Olaizola - Adjunct Professor

Dr Jaime Olaizola is Director of the company IDForest based in Palencia, Spain and is in Prof Cormac Murphy's lab on secondment as part of the EU RISE project 3D Neonet co-cordinated by Prof Breandán Kennedy.  IDForest is a Technology-Based Company specialising in working with fungi. Its main work is in the development of cultivation methods of edible, medicinal mushrooms and the biological control of plant diseases using mycorrhizal fungi.

Ena Prosser - Adjunct Professor

Dr Ena Prosser is a Partner in Fountain Healthcare Partners. An immunologist by training, Ena has a broad background in international alliance and intellectual property management. She has led rigorous due diligence projects on technologies and products within the Specialty Pharma, diagnostic, device and biotechnology areas.  Prior to helping establish Fountain, Ena led Enterprise Ireland’s life science group where she assisted a number of Irish starts ups.

 

Visiting Staff

Matthias Landgraf - Visiting Professor

 Reader in Developmental Neurobiology, Department of Zoology, University of Cambridge.

 

Emeritus Staff

William (Liam) Fogarty

  • Emeritus Professor of Industrial Microbiology

Paul Engel MRIA

  • Emeritus Professor of Biochemistry
  • email: paul.engel@ucd.ie

Alan Keenan

  • Emeritus Professor of Pharmacology
  • email: alan.keenan@ucd.ie

Paul Malthouse MRIA

  • Emeritus Professor of Biochemistry
  • email: j.paul.g.malthouse@ucd.ie

Finian Martin

  • Emeritus Professor of Pharmacology
  • email: finian.martin@ucd.ie

Stephen Mayhew MRIA

  • Emeritus Professor of Biochemistry
  • email: stephen.mayhew@ucd.ie

Michael Ryan

  • Emeritus Professor of Pharmacology